Table 1.
Demographics, comorbidities, and presentation of COVID-19 in HIV patients
| Author/year | Age (years)/sex (M/F) | Country | Past medical history | Cardiovascular/pulmonary comorbidities | Contact history | Presenting symptoms | Meantime from exposure to infection |
|---|---|---|---|---|---|---|---|
| Jin Sun et al./2020 | 37/M | Singapore | None | None | NA | Fever, sore throat, dry cough, and headache | NA |
| Toombs et al./2020 | 62/M | UK |
Renal transplant 2012 T2DM on insulin Hypertension Latent tuberculosis |
HTN | NA | Dyspnea and a dry cough | NA |
| Toombs et al./2020 | 46/M | UK |
Smoker G6PD deficiency |
None | NA | Productive cough and fevers | NA |
| Toombs et al./2020 | 57/F | UK |
Hypertension T2DM Obesity Stroke 2007 Graves’ disease—in remission Reflux |
HTN | NA | Dyspnea, a dry cough, fevers, anorexia, and headaches | NA |
| Menghua et al./2020 | 49/F | China | Cured syphilis and viral pneumonia | None | NA | Fever, pharyngeal pain, and chills | NA |
| Giambenedetto et al./2020 | 75/M | Italy? | HIV, hep B | HTN | NA | High fever, diarrhea, and cough | NA |
| Choi et al./2020 | 71/M | South Korea | None | HT | NA | Fever and cough | NA |
| Choi et al./2020 | 67/F | South Korea | None | None | NA | Fever and myalgia | NA |
| Müller et al. 2020 | 55/M | Austria | HCV, HCC, cirrhosis, and liver transplant | None | A friend with flu symptom | Fever, fatigue, and tachycardia | 12 days |
| Ali asadollahi-amin et al./2020 | 44/M | Iran | Rib fracture | None | NA | Chest pain and local tenderness | NA |
| Ridgway et al./2020 | 38/M | USA | None | DM, HTN, OSA, and obesity | NA | Headache, myalgia, SOB, fever, diarrhea, and tachycardia | NA |
| Ridgway et al./2020 | 50/F | USA | None | Obesity | NA | Fever, cough, SOB, and headache | NA |
| Ridgway et al./2020 | 51/F | USA | Latent tuberculosis | None | NA | Fever, cough, SOB, and diarrhea | NA |
| Ridgway et al./2020 | 53/F | USA | Esophageal strictures and bronchoesophageal and tracheoesophageal fistulas | None | Denied sick contacts | Fever, cough, vomiting, and diarrhea | NA |
| Ridgway et al./2020 | 47/F | USA | HF (LVEF-15%), ICD, PE, and CVA | HTN, obesity, and COPD | Denied sick contacts | Chest pain, SOB, tachycardia, abdominal pain, and diarrhea | NA |
| Haddad et al./2020 | 41/M | USA | Recurrent HSV | None | Indirect exposure to a COVID-19-positive patient | Abdominal pain, vomiting, dry cough, intermittent fever, and confusion | NA |
| Zhu et al./2020 | 61/M | China |
DM Chronic smoker |
None | NA | Fever and dry cough | NA |
| Chen et al./2020 | 24/M | China | None | None | NA | Fever and dry cough | NA |
| Wu et al./2020 | 61/M | China | Pulmonary TB and DM | None | NA | Generalized myalgia, intermittent fever, fatigue, sob, and productive cough | NA |
| Wu et al./2020 | 47/M | China | None | None | NA | Fever, generalized myalgia, sore throat, cough, intermittent shortness of breath, and diarrhea | NA |
| Patel et al./2020 | 58/M | USA | None | None | NA | Weakness, anorexia, and diarrhea | NA |
| Iordanou et al./2020 | 58/M | Cyprus | Influenza A and B | None | NA | Dry cough, malaise, and fever | NA |
| Sadr et al./2020 | 57/F | Iran | None | None | A pharmacist exposed to COVID-19 patients | Headache, malaise, and fever | NA |
| Wang et al./2020 | 37/F | China | None | None | NA | Fever, dry cough, chest hypoxia, tachypnea, high BP, and tachycardia | NA |
| Benkovic et al./2020 | 56/M | USA | None | HLD | Trip to Florida |
Fatigue anosmia ageusia |
NA |
| Benkovic et al./2020 | 56/M | USA | None | HTN | NA | Fever and fatigue | NA |
| Benkovic et al./2020 | 62/M | USA | HCV |
HTN HLD |
NA | Fever, nonproductive cough, fatigue, and watery diarrhea | NA |
| Benkovic et al./2020 | 65/M | USA | AFIB, DM |
HTN HLD |
NA | Cough, fever, and hypoxia | NA |
| Blanco et al./2020 | 40/transgender | USA | None | None | NA | URTI, fever, cough, malaise, headache, and high BP | NA |
| Blanco et al./2020 | 49/M | USA | Hypothyroidism | None | HCW | LRTI, fever, and cough PaO2–182 | NA |
| Blanco et al./2020 | 29/M | USA | None | None | Sexual worker participant in chemsex session | URTI-fever, cough, malaise, and headache | NA |
| Blanco et al./2020 | 40/M | USA | Asthma | None | Dinner 5 days before with another person who was COVID-19 positive | Lower respiratory tract infection-fever, cough, malaise, headache, dyspnea, and tachycardia | NA |
| Blanco et al./2020 | 31/transgender | USA | None | None | NA | Lower respiratory tract infection-fever, cough, dyspnea, and tachycardia | NA |
| Suwanwongse et al./2020 | 37/M | USA |
Tertiary syphilis HCV |
None | NA |
Cough Myalgia Rhinorrhea \ |
NA |
| Suwanwongse et al./2020 | 31/M | USA | None | Obesity and HLD | NA | Dyspnea, cough, fever, and tachycardia | NA |
| Suwanwongse et al./2020 | 70/M | USA | AFIB, HF, HCV, and COPD | HTN and HLD | NA | Dyspnea, tachycardia, and tachypnea | NA |
| Suwanwongse et al./2020 | 76/F | USA | DM | None | NA | Cough and fever | NA |
| Suwanwongse et al./2020 | 63/M | USA | HTN | None | NA | Watery diarrhea, vomiting, and fever | NA |
| Suwanwongse et al./2020 | 52/M | USA | DM | None | NA | Dyspnea, tachycardia, and tachypnea | NA |
| Suwanwongse et al./2020 | 58/M | USA | DM | HTN, HLD, and COPD | NA | Fever, cough, dyspnea, tachycardia, and tachypnea | NA |
| Suwanwongse et al./2020 | 52/M | USA | HCV | HTN, HLD, and COPD | NA | Fever, cough, dyspnea, tachycardia, and tachypnea | NA |
| Suwanwongse et al./2020 | 76/F | USA | AFIB | HTN, pulmonary HTN, and COPD | NA | Fever, cough, dyspnea, and tachypnea | NA |
| Nakamoto et al./2020 | 28/M | Japan | Smoking, alcohol drinking, and HBV (+) | None | NA | Pneumonia | NA |
HTN, hypertension; DM, diabetes mellitus; HSV, herpesvirus; NHL, non-Hodgkin’s lymphoma; AFIB, atrial fibrillation; HID, hyperlipidemia; COPD, chronic obstructive pulmonary disease; HCV, hepatitis C virus; URTI/LRTI, upper/lower respiratory infection; HBV, hepatitis B virus; HF, heart failure